The provision of continuous renal replacement therapies (CRRT) to small children has generally required the adaptation of adult machines and modified operational characteristics. CRRT prescription for younger and smaller children versus adults differs significantly due to problems concerning the extracorporeal blood volume, the need for circuit blood priming, and the adaptation of machines designed for adult-sized patients. Moreover, the provision of renal replacement therapy to infants and neonates presents a unique problem: no more than 10-15% of their blood volume should be removed by the extracorporeal circuit to prevent hypotension and anemia. In 2012, a dedicated machine, i.e. the Cardio-Renal, Pediatric Dialysis Emergency Machine (CARPEDIEM), was developed and launched the ‘fitted era' for pediatric CRRT. In this review, we analyze how CRRT techniques have evolved for pediatric application and describe the first in vivo application of the CARPEDIEM for the safe and efficacious provision of CRRT to infants.

Keywords:
Continuous renal replacement therapy, Infants, Extracorporeal therapy
1.
Goldstein SL: Pediatric acute renal failure: demographics and treatment. Contrib Nephrol 2004;144:284-290.
2.
Schneider J, et al: Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med 2010;38:933-939.
3.
Uchino S, et al: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-818.
4.
Ostermann M, Chang RW: Correlation between parameters at initiation of renal replacement therapy and outcome in patients with acute kidney injury. Crit Care 2009;13:R175.
5.
Askenazi DJ, et al: Continuous renal replacement therapy for children ≤10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 2013;162:587-592.e3.
6.
Symons JM, et al: Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 2003;41:984-989.
7.
Kramer P, et al: Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 1977;55:1121-1122.
8.
Ronco C, et al: Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration. Kidney Int 1986;29:908-915.
9.
Canaud B, et al: Pump assisted continuous venovenous hemofiltration for treating acute uremia. Kidney Int 1988;24:S154-S156.
10.
Yorgin PD, Krensky AM, Tune BM: Continuous venovenous hemofiltration. Pediatr Nephrol 1990;4:640-642.
11.
Zobel G, et al: Five years experience with continuous extracorporeal renal support in paediatric intensive care. Intensive Care Med 1991;17:315-319.
12.
Warady BA, Bunchman T: Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 2000;15:11-13.
13.
Goldstein SL: Advances in pediatric renal replacement therapy for acute kidney injury. Semin Dial 2011;24:187-191.
14.
Hackbarth R, et al: The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs 2007;30:1116-1121.
15.
del Castillo J, et al: Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Crit Care 2008;12:R93.
16.
Goldstein SL, et al: Evaluation of the PRISMA M10 circuit in critically ill infants with acute kidney injury: a report from the Prospective Pediatric CRRT Registry Group. Int J Artif Organs 2006;29:1105-1108.
17.
Sohn YB, et al: Continuous renal replacement therapy in neonates weighing less than 3 kg. Korean J Pediatr 2012;55:286-292.
18.
Eding DM, et al: Innovative techniques to decrease blood exposure and minimize interruptions in pediatric continuous renal replacement therapy. Crit Care Nurse 2011;31:64-71.
19.
Ronco C, et al: Management of fluid balance in CRRT: a technical approach. Int J Artif Organs 2005;28:765-776.
20.
Ronco C, Garzotto F, Ricci Z: CA.R.PE.DI.E.M. (Cardio-Renal Pediatric Dialysis Emergency Machine): evolution of continuous renal replacement therapies in infants - a personal journey. Pediatr Nephrol 2012;27:1203-1211.
21.
Ronco C, et al: Renal replacement and extracorporeal blood therapies in neonates: a paradigm shift. Lancet 2014, in press.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.